Navigation Links
Intrexon Announces Third Quarter Financial Results
Date:11/7/2013

ed probiotics for the treatment of diseases of the oral cavity, throat, sinus and esophagus that will be designed to work orally rather than through the digestive system with a goal of increasing the probability of effective treatment outcomes.

In 2011, we entered into our first collaboration and have steadily increased the number over the past three years, entering into new agreements and expanding existing ECCs.  To date, we have entered into 17 such agreements and expansions with 14 different counterparties, of which 16 remain active.  We have 14 active ECCs, including one expansion, and two research collaborations that we anticipate could, if successful, become ECCs.  Under the ECCs, we are developing products in the fields of healthcare and food. In healthcare, our ECCs include programs in oncology, anti-infectives, antibiotics and tissue repair. In food, we are working to increase the productivity and nutritional value of salmon and other fish. We are also working to establish ECCs in the areas of energy and environmental sciences. 

Third Quarter 2013 Financial Results Compared to Prior Year PeriodTotal revenues were $6.1 million for the three months ended September 30, 2013 compared to $2.9 million for the three months ended September 30, 2012, an increase of $3.2 million, or 109.7%. The $3.1 million increase in collaboration revenue resulted primarily from the recognition of deferred revenue for upfront payments received from five collaborations signed by Intrexon between October 1, 2012 and September 30, 2013, as well as one milestone payment received in October 2012.  Revenues also increased as a result of research and development services the Company performed under these new agreements.  Research and development services revenue covered 28% and 12% of total operating expenses for the three months ended September 30, 2013 and 2012, respectively.

Research and development expenses were $10.8 million for t
'/>"/>

SOURCE Intrexon Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Soligenix and Intrexon Pursue Melioidosis Therapy Through Worldwide Exclusive Collaboration
2. Misonix, Inc. Announces First Quarter Fiscal Year 2014 Financial Results
3. Pro-Dex, Inc. Announces Fiscal 2014 First Quarter Financial Results Conference Call And Webcast
4. DURECT Announces Proposed Public Offering of Common Stock
5. Cellular Biomedicine Group Announces November 07, 2013 as Voting Deadline for Its Annual Shareholder Meeting
6. Star Scientific Announces Leadership Transition, Acceleration of Plans for Submission of an IND to FDA for Pharmaceutical Version of Anatabine Compound
7. Echo Therapeutics Announces Third Quarter 2013 Financial Results
8. Regado Biosciences, Inc. Announces Third Quarter 2013 Results
9. PDL BioPharma Announces Third Quarter 2013 Financial Results
10. Regulus Announces Timing for Third Quarter 2013 Financial Results Webcast and Conference Call
11. Heska Announces Financial Results for the Third Quarter of Fiscal 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 1, 2014 Sophia Genetics, ... domaine de l,analyse des données issues du SNG ... de diagnostic in vitro (IVD) du gène CFTR ... la mucoviscidose dans un seul essai SGN. La ... les types de variantes par l,intermédiaire d,un seul ...
(Date:9/30/2014)... 2014  Wrightington, Wigan and ... MDRX ) are delighted to announce WWL,s decision ... health information system. The system will be implemented across ... way WWL delivers healthcare in the future. ... of on-time and on-budget system implementations as well as ...
(Date:9/30/2014)... 2014 This study provides an analysis ... solutions including nuclear imaging informatics, PET imaging informatics, ... assesses the size of the market based on ... projects future growth based on the current drivers ... place in the broader markets for imaging equipment, ...
Breaking Medicine Technology:Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 2Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 3Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 2Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 3Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 4Analysis of the US Molecular Imaging Informatics Market 2Analysis of the US Molecular Imaging Informatics Market 3
... 10, 2010 The American Council on Exercise (ACE), ... fitness certification, education and training organization in the world, ... will focus on eliminating obesity in America.  As an ... the critical need to regularly engage in physical activity ...
... 2010 Luminex Corporation (Nasdaq: LMNX ... the Stephens Fall Investment Conference to be held ... (Logo:   http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) (Logo:   ... Patrick J. Balthrop, president and chief executive officer, ...
Cached Medicine Technology:American Council on Exercise (ACE) Announces Nationwide Effort to Eliminate Obesity in America 2American Council on Exercise (ACE) Announces Nationwide Effort to Eliminate Obesity in America 3Luminex Corporation to Present at Stephens Fall Investment Conference 2
(Date:10/1/2014)... MO (PRWEB) October 01, 2014 Join the ... Castlewood Eating Disorder Treatment Center’s first ever charity golf tournament ... for people with eating disorders who cannot afford treatment. The ... Golf Club in Eureka, Mo. , The day-long event ... noon. A reception and award dinner will begin at 5 ...
(Date:10/1/2014)... October 01, 2014 Diet Doc understands that ... to lose weight and their dieting attempts could be easily ... Including hormone diet treatments into their programs as ... to see fast and effective weight loss results, it also ... healthy habits to maintain their weight for the future. , ...
(Date:10/1/2014)... the occasion of the Leishmaniasis East Africa Platform ... international leishmaniasis experts, results of a pharmacovigilance ... plan, carried out by MSF, DNDi, and national ... presented to key decision makers in order to ... the combination of Sodium Stibogluconate and Paromomycin (SSG&PM) ...
(Date:10/1/2014)... Today marks the final day prosthodontist Dr. ... Oxnard and Woodland Hills, Calif., is in the southern ... , “Speaking to this group of specialists allows more ... the help and care they deserve,” Dr. Jivraj said. ... work, providing cosmetic dentistry, correcting bite issues, placing implants, ...
(Date:10/1/2014)... Brecksville, OH (PRWEB) October 01, 2014 This ... of direct to consumer lab testing, is offering 10% off ... promo code DIBN10 when placing their order to save. ... people in the United States are affected by Diabetes. ... for Diabetes to go undiagnosed until it causes serious health ...
Breaking Medicine News(10 mins):Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4Health News:Results of large-scale roll out of combination treatment for kala-azar in Eastern Africa 2Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 2Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 3Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 4Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 5Health News:Request A Test Offers 10% off Diabetes Testing in October 2014 2Health News:Request A Test Offers 10% off Diabetes Testing in October 2014 3
... (WHI) confirm that combination hormone therapy increases the risk of ... trend toward an increased risk of heart disease during the ... therapy within 10 years of menopause, and a more marked ... than 10 years after menopause. Analyses indicate that overall ...
... Feb. 15, 2010 Simple urine tests for four ... people with lupus, researchers at UT Southwestern Medical Center have ... years before such tests could be used clinically, the findings ... in use, the researchers said. "Our goal was to ...
... thought they were fine, while their docs disagreed , TUESDAY, ... and diabetes, a new survey has found that a majority ... everyone else who has the problem. , More than 50 ... in the wrong direction." In contrast, only 17 percent said ...
... Telecom ... ... Group, a Harte-Hanks Company has released a new benchmark report entitled Recovering with Telecom ... solutions as a strategic foundation and precursor for other communications and network investments in ...
... ... professionals and scientists doing the critical work of IP research are seeking the best ... includes lunch and roundtable discussion., , ... (Vocus) February 16, 2010 -- GenomeQuest will hosts a seminar focused ...
... YORK , Feb. 16 Paco Sosa , ... had cheated death several times in recent years, passed away on ... , According to his companion, filmmaker Bernadine Santistavan, Paco acknowledged his ... him go. , For Dr. Thalia Goldberg at Park ...
Cached Medicine News:Health News:WHI data confirm short-term heart disease risks of combination menopausal hormone therapy 2Health News:WHI data confirm short-term heart disease risks of combination menopausal hormone therapy 3Health News:WHI data confirm short-term heart disease risks of combination menopausal hormone therapy 4Health News:Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find 2Health News:Most Americans Think It's Others Who Are Unhealthy 2Health News:Most Americans Think It's Others Who Are Unhealthy 3Health News:AnchorPoint Sponsored Aberdeen Group Report Addresses Telecom Lifecycle Management 2Health News:AnchorPoint Sponsored Aberdeen Group Report Addresses Telecom Lifecycle Management 3Health News:AnchorPoint Sponsored Aberdeen Group Report Addresses Telecom Lifecycle Management 4Health News:AnchorPoint Sponsored Aberdeen Group Report Addresses Telecom Lifecycle Management 5Health News:GenomeQuest Hosts Seminar Focused On Web-based Searching for Patent Information Across Global Sequence Databases 2Health News:Manhattan's Oldest Dog Dies, Leaves Behind a Legacy of Teaching 2
... Millipore has developed a range of ... match specific water quality requirements. Each ... is designed to specifically target contaminants ... HPLC, molecular biology and ICP-MS. The ...
Adjustable speed vortex with inter-changeable heads , 110 V...
Inquire...
Adjustable speed vortex with inter-changeable heads, 110 V...
Medicine Products: